Community Bank’s PDL BioPharma, Inc. PDLI Stock Holding History

Community Bank’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,000	Closed	-$14K	–	489
2015 Q4	$14K	Hold	4,000	–	–	﹤0.01%	342
2015 Q3	$20K	Hold	4,000	–	–	0.01%	272
2015 Q2	$26K	Hold	4,000	–	–	0.01%	264
2015 Q1	$28K	Hold	4,000	–	–	0.01%	261
2014 Q4	$31K	Buy	+4,000	New	+$31.7K	0.01%	254

Other funds holding PDLI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Community Bank's PDLI Position: Q1 2016 in Review

Community Bank sold out of PDL BioPharma, Inc. (PDLI) in Q1 2016, closing a stake of 4,000 shares — an estimated $14K sold.

Community Bank first reported a position in PDLI in Q4 2014 and held it in 5 quarters. The position peaked at $31K in Q4 2014. 195 funds tracked by Wall St. Rank hold PDLI as of Q1 2016.

Community Bank reported no remaining PDL BioPharma, Inc. position as of Q1 2016 after selling out during the quarter.
Community Bank sold 4,000 PDL BioPharma, Inc. shares in Q1 2016, an estimated $14K.
Community Bank first reported a position in PDL BioPharma, Inc. in Q4 2014 and held it in 5 quarters.
Community Bank's PDL BioPharma, Inc. position peaked at $31K in Q4 2014.
195 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2016.

Based on Community Bank's 13F filing for Q1 2016, filed 20 Apr 2016.